Chen F, Tang H, Li C, Kang R, Tang D, Liu J
Nat Commun. 2025; 16(1):2278.
PMID: 40055353
PMC: 11889236.
DOI: 10.1038/s41467-025-57583-2.
Du L, Cui Y, Zhou Y, Kwaku O, Ding X, Zeng L
Hereditas. 2025; 162(1):22.
PMID: 39953634
PMC: 11827142.
DOI: 10.1186/s41065-025-00388-6.
Liu Y, Ding J, Li S, Jiang A, Chen Z, Quan M
Cell Oncol (Dordr). 2025; .
PMID: 39903418
DOI: 10.1007/s13402-025-01038-9.
Norris D, Aw Y, Yang H
Life Metab. 2025; 2(2):load003.
PMID: 39872734
PMC: 11749630.
DOI: 10.1093/lifemeta/load003.
Xiong Q, Zhu Z, Li T, Li X, Zhou Z, Chao Y
Nat Struct Mol Biol. 2025; .
PMID: 39824977
DOI: 10.1038/s41594-024-01474-5.
Acetyl-L-carnitine ameliorates atherosclerosis in LDLR mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis.
Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X
Front Nutr. 2024; 11:1509577.
PMID: 39737151
PMC: 11684389.
DOI: 10.3389/fnut.2024.1509577.
Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury.
Yang K, Zhang P, Li J, Zhang G, Chang X
J Pharm Anal. 2024; 14(11):101034.
PMID: 39720623
PMC: 11667710.
DOI: 10.1016/j.jpha.2024.101034.
Targeting squalene epoxidase in the treatment of metabolic-related diseases: current research and future directions.
Chen M, Yang Y, Chen S, He Z, Du L
PeerJ. 2024; 12:e18522.
PMID: 39588004
PMC: 11587872.
DOI: 10.7717/peerj.18522.
The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B-Cell Lymphoma.
Zhu Z, Jiang W, Zhou J, Maldeney A, Liang J, Yang J
Cancer Med. 2024; 13(21):e70342.
PMID: 39501600
PMC: 11538279.
DOI: 10.1002/cam4.70342.
Targeted protein degradation: advances in drug discovery and clinical practice.
Zhong G, Chang X, Xie W, Zhou X
Signal Transduct Target Ther. 2024; 9(1):308.
PMID: 39500878
PMC: 11539257.
DOI: 10.1038/s41392-024-02004-x.
A distributed integral control mechanism for regulation of cholesterol concentration in the human retina.
Scheepers R, Levi N, Araujo R
R Soc Open Sci. 2024; 11(10):240432.
PMID: 39479233
PMC: 11521609.
DOI: 10.1098/rsos.240432.
TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease.
Lu J, Wu K, Sha X, Lin J, Chen H, Yu Z
Transl Neurodegener. 2024; 13(1):52.
PMID: 39468688
PMC: 11520887.
DOI: 10.1186/s40035-024-00445-6.
Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces.
Romani P, Benedetti G, Cusan M, Arboit M, Cirillo C, Wu X
Nat Cell Biol. 2024; 26(12):2046-2060.
PMID: 39433949
PMC: 11628398.
DOI: 10.1038/s41556-024-01527-3.
Glutamine sensing licenses cholesterol synthesis.
Garcia B, Melchinger P, Medeiros T, Hendrix S, Prabhu K, Corrado M
EMBO J. 2024; 43(23):5837-5856.
PMID: 39433901
PMC: 11612431.
DOI: 10.1038/s44318-024-00269-0.
Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma.
Zhong Y, Geng F, Mazik L, Yin X, Becker A, Mohammed S
Cell Rep Med. 2024; 5(9):101706.
PMID: 39236712
PMC: 11524980.
DOI: 10.1016/j.xcrm.2024.101706.
Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy.
Zhou Z, Xu J, Liu S, Lv Y, Zhang R, Zhou X
Biomark Res. 2024; 12(1):97.
PMID: 39227959
PMC: 11373505.
DOI: 10.1186/s40364-024-00630-9.
Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases.
Xu X, Jin W, Chang R, Ding X
Front Immunol. 2024; 15:1398921.
PMID: 39224584
PMC: 11366632.
DOI: 10.3389/fimmu.2024.1398921.
Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions.
Li X, Li M
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204178
PMC: 11358954.
DOI: 10.3390/ph17081073.
Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids.
Tian J, Goldstein J, Li S, Schumacher M, Brown M
Proc Natl Acad Sci U S A. 2024; 121(34):e2409262121.
PMID: 39145929
PMC: 11348305.
DOI: 10.1073/pnas.2409262121.
Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.
Llanso L, Segarra-Casas A, Dominguez-Gonzalez C, Malfatti E, Kapetanovic S, Rodriguez-Santiago B
Neurol Neuroimmunol Neuroinflamm. 2024; 11(5):e200285.
PMID: 39106428
PMC: 11309561.
DOI: 10.1212/NXI.0000000000200285.